Table 3. Clinical outcomes after 5 years of follow-up.

Outcomes	BMS	PES	SES	BMS vs. PES	BMS vs. SES	SES vs. PES
Cardiac death	0	4.8	5.1	0.1	0.1	0.9
Cardiac death or MI	9	12.3	11.8	0.6	0.6	>0.9
TVR	31.8	14.1	12.9	0.004	0.001	0.7
TLR	30.3	11.4	11.2	0.002	0.002	>0.9
MACE	35.3	22.5	16.8	0.046	0.006	0.4

Numbers are proportions. BMS, bare metal stent; MACE, major cardiac adverse events (a composite of cardiac death, myocardial infarction or ischemia-driven target vessel revascularization); MI, myocardial infarction; PES, paclitaxel-eluting stet; SES, sirolimus-eluting stent; TLR, ischemia driven target lesion revascularization; TVR, ischemia driven target vessel revascularization.